NYSCF – Robertson Investigator Advances New Strategies for Tumor Genome Mapping

NYSCF – Robertson Stem Cell Investigator Dr. Feng Zhang, Broad Institute of MIT and Harvard, used a gene editing technology called CRISPR/Cas-9 mediated loss-of-function screen to conduct a full-body, genome-wide analysis of tumor growth and metastasis in mice.

Published in Cell, this screening technique sets the stage for potential future use in identifying genetic evolution of different types of cancer in vivo.

 

Read the paper in Cell >>

Diseases & Conditions:

Genomics & Gene Editing

People mentioned: